Since 2012, SATT Conectus has been detecting inventions that originate in Alsace's public research laboratories and investing financially in their technological development. Our objective: to transfer these innovative technologies to companies in order to industrialize them and launch them on the market.
The innovative technologies supported by Conectus
Developing a new therapy against cancer, countering antibiotic resistance, making a window "smart", developing a new waterproofing treatment, imagining a new detector for pollutants in ambient air, treating the adverse effects of chemotherapies... Each year, some fifteen innovative projects led by Alsatian researchers benefit from a financial investment from Conectus (up to €500k / project) to gain in maturity and become innovative products or services accessible to all on the market.
In which areas does Conectus invest in innovative projects?
Health(1)
Medical technologies
Chemicals / Materials
49%
11%
17%
Engineering(2)
Energy / ecotechnologies
ICT(3)
12%
8%
4%
(1) Therapeutics and diagnosis
(2) Robotics, mechanics, electronics....
(3) Digital, IT....
Results are in!
113
innovative projects supported by Conectus since 2012
36,4 M€
invested by Conectus in innovative projects since 2012
320 k€
invested on average per innovative project (year 2017)
103
technology transfers since 2012
154
jobs created since 2012 to develop these innovative projects
40 %
of innovative projects are developed in co-conception
+ 10M€
of revenues from cumulative technology transfers since 2012
167
active intellectual property titles managed
100 %
innovative projects that have benefited companies established in France
(of which 40% are SMEs)